STEMdiffTM Atrial Cardiomyocyte Differentiation Kit and 8 more items

The University of Virginia has awarded contract A207_PO-0457138-V3 to Quartzy, effective July 18, 2026. This purchase order encompasses specialized laboratory and pharmaceutical supplies intended for cellular research and development applications. The contract line items include cardiomyocyte differentiation and dissociation kits—products designed for stem cell differentiation protocols—along with cell culture-grade water and sterile polypropylene centrifuge tubes of varying capacities (15 milliliter and 50 milliliter). These items are characterized as supplies to be delivered to the contracting organization located in Virginia.

The award also includes pharmaceutical compounds comprising genistein, desloratidine, cyclizine hydrochloride, and metergolidine, which are supplied in quantities measured by weight (milligrams or grams as appropriate). The contract structure indicates unit pricing on individual line items; however, specific contract value, cumulative value, and period of performance details were not provided in the available documentation. All items are designated for delivery to the University of Virginia as the buying entity.